| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.06 | 0.3 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.066 | 0.3 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |